The rapidly-expanding drug delivery industry works to make lifesaving compounds more bioavailable—while pharmaceutical companies work to extend their patents.
Eastman Drug Delivery Systems were built around novel IP that allowed greater oral bioavailability of important drugs like paclitaxel (improved permeability) and tamoxifen (improved solubility).
I worked with technical experts and a medical illustrator to take four brochures from napkin drawings to printed sales tools in less than four weeks—in time for a key bioavailability symposium. Two of these pieces are shown here.
PERMEABILITY
(to improve a drug's ability to cross the intestinal membrane by inhibiting CYP3A and p-gp activity)
SOLUBILITY
(using a new class of H-Ben cyclodextrins to add value to hydrophobic drugs)
